Medication adherence leads to lower health care use and costs despite increased drug spending.
about
Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributorsEffect of drug reminder packaging on medication adherence: a systematic review revealing research gapsThe effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature.Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literaturePattern of statin use in southern italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment?Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis.Multidrug punch cards in primary care: a mixed methods study on patients' preferences and impact on adherence.Self-monitoring of lower leg skin temperature: accuracy of self-reported data and adherence to a cooling protocol for the prevention of venous leg ulcers.Getting less of what you want: reductions in statistical power and increased bias when categorizing medication adherence data.Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims data.Mobile Phone Apps to Improve Medication Adherence: A Systematic Stepwise Process to Identify High-Quality Apps.Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomes.Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea.Importance of including early nonadherence in estimations of medication adherence.Medication adherence: process for implementationStatin pharmacogenomics: opportunities to improve patient outcomes and healthcare costs with genetic testingRetrospective analysis of long-term adherence to and persistence with DPP-4 inhibitors in US adults with type 2 diabetes mellitus.Highlighting differences between conditional and unconditional quantile regression approaches through an application to assess medication adherence.Medication adherence and readmission after myocardial infarction in the Medicare populationIncidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials.A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence.Adherence to Insulin Pen Therapy Is Associated with Reduction in Healthcare Costs Among Patients with Type 2 Diabetes MellitusAn introductory pharmacy practice experience on improving medication adherence.Reconsideration of key articles regarding medication-related problems in older adults from 2011.Medication Adherence Patterns after Hospitalization for Coronary Heart Disease. A Population-Based Study Using Electronic Records and Group-Based Trajectory Models.Improving health outcomes: innovation, coverage, quality and adherence.Medication Nonadherence Before Hospitalization for Acute Cardiac EventsNovel Adherence Measures for Infusible Therapeutic Agents Indicated for Rheumatoid ArthritisEnhancing adherence of antihypertensive regimens in hypertensive African-Americans: current and future prospects.Adherence to cardiovascular medications: lessons learned and future directions.Integrative health coaching: a behavior skills approach that improves HbA1c and pharmacy claims-derived medication adherence.Patient characteristics associated with medication adherence.Predictors of Difficulty in Medication Intake in Europe: a Cross-country Analysis Based on SHARE.Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventionsThe Clinical and Economic Impact of the V-Go® Disposable Insulin Delivery Device for Insulin Delivery in Patients with Poorly Controlled Diabetes at High RiskImpact of Hospitalization for Acute Myocardial Infarction on Adherence to Statins Among Older Adults.Comparison of adherence and persistence among adults with type 2 diabetes mellitus initiating saxagliptin or linagliptin.Using quantile regression to assess disparities in medication adherence.Associations between adherence and outcomes among older, type 2 diabetes patients: evidence from a Medicare Supplemental database.Medication adherence and health care utilization in pediatric chronic illness: a systematic review.
P2860
Q26741537-ABBA5B79-9B27-4BE3-A587-EF842091DF9DQ26862555-6865E6A4-0090-4C53-B750-DD0CD9B1D4D3Q26864768-27B6740A-4AA8-4717-B689-0EFCFA01FAD1Q27015089-B27E4E54-5CF6-4887-95D6-2F66B2B3DEC4Q28541300-3B96F8BF-D5FA-4345-9F04-8732E3BF1B69Q30539620-1406E2B7-DE2B-41E8-920C-2EC3706459F8Q30588645-8CB009C6-4284-4E90-8C81-B772362568BCQ31034585-743DB8F8-212D-4277-9FCD-930177B1116CQ31049583-A39704A1-87E1-4C47-A49B-F9039CF709E1Q31161075-B6A39F07-1E16-4EA7-A0DD-39C8BD394961Q33451747-35742B0B-ED71-4C51-A1C8-643046417D37Q33652884-43CB6A1E-7779-4E93-BE50-4424A7AE233DQ33795926-CC53860B-F9AC-4CFA-9603-88B33718EB42Q33852705-3B9EC4B9-61A0-4506-920E-DFA4D1DC599CQ34005496-AC769EA1-0A3B-41F0-B66F-92EC6735E933Q34608646-3D00894E-F477-41E0-82E5-95A1F10485E0Q34737169-7912BF3B-3180-4F96-94AC-0BCA390FEA15Q34809210-AB130DC1-9F8E-430D-A53B-4F61855AA541Q35063975-6EB4710A-047F-4602-B15F-535648C4AC61Q35684200-60C7AEE7-2844-4E8E-9FDF-2D39AF56C79EQ35684220-398B3D25-158C-4BD0-8421-0E2124047819Q35741281-22207E81-2931-4AEA-8241-558385F82FACQ35891066-3591982A-D1CB-4F70-9F80-30CD9C0D54DAQ36043785-6BE563AD-4A51-494E-8EEF-FD46283098F2Q36110118-15F176C9-A64B-4F6B-9E1F-FACEE51ED3CDQ36411429-A99B0FF0-4518-43E8-98B6-9BF6459955B7Q36443765-FA6C8D1A-1FB7-42DC-9238-EB68E4D5EEFAQ36480601-288FCAF2-8832-46AA-971F-607F6C98324CQ36566381-F5EC6F47-5EF7-4A73-94B1-AF9E5E7A33D4Q36804187-A2C75C6A-FFCB-4B8E-8CB0-7768DF6AAEC5Q36919682-121D2C5C-4603-4516-8E9F-BE18F2BFDCA0Q36954729-7AFDC37E-C69A-4804-9FDC-5F9287DAEA81Q36983492-2C97FAD4-B3C1-407C-B038-52F9D3949993Q37014474-3B637C22-46A1-4B67-B70F-43E0B6F5B9F3Q37022927-672C3029-0598-450D-9B5A-946430259A25Q37116113-4488DE8A-7BBD-42BB-8140-55997EB3B0AEQ37164571-592FE6B5-E256-4F15-9C79-61284249FEF6Q37184314-DC6830F1-24C9-489D-8ABA-2DB01B7DCDCBQ37194308-EBB5C87E-3B28-4D49-BFC9-DE7AA6E2BB20Q37200368-EC840C66-8E72-42E6-8F15-651DECCF7E06
P2860
Medication adherence leads to lower health care use and costs despite increased drug spending.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Medication adherence leads to ...... spite increased drug spending.
@en
Medication adherence leads to ...... spite increased drug spending.
@nl
type
label
Medication adherence leads to ...... spite increased drug spending.
@en
Medication adherence leads to ...... spite increased drug spending.
@nl
prefLabel
Medication adherence leads to ...... spite increased drug spending.
@en
Medication adherence leads to ...... spite increased drug spending.
@nl
P2093
P1433
P1476
Medication adherence leads to ...... spite increased drug spending.
@en
P2093
Joshua N Liberman
M Christopher Roebuck
Marin Gemmill-Toyama
Troyen A Brennan
P356
10.1377/HLTHAFF.2009.1087
P407
P577
2011-01-01T00:00:00Z